GLP-1 Trends Informing Holistic Kidney Care

Nov. 20, 2025

GLP-1s, once seen primarily through the lens of type two diabetes management, are now being recognized for their profound protective benefits for both cardiovascular and kidney health. Now, the healthcare community is leveraging evolving research to engage in a broad re-evaluation of how it manages costly chronic...

READ MORE

Press Releases
DaVita Inc. to Participate in the BofA Securities 2026 Health Care Conference
May 6, 2026

DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with...

DaVita Inc. 1st Quarter 2026 Results
May 5, 2026

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2026. "DaVita's foundation is clinical excellence, driven by operating rigor that produces durable...

DaVita Inc. Schedules 1st Quarter 2026 Investor Conference Call
Apr 20, 2026

DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Tuesday, May 5, 2026, at 5:00 p.m. Eastern Time. The company plans to...

Read more